March 2020 FDA Recall Drug by H J Harkins Company Inc Dba Pharma Pac
D-1005-2020 - Presence of Foreign Tablets/Capsules

This Class II drug recall was voluntarily initiated by H J Harkins Company Inc Dba Pharma Pac on March 6, 2020 for the product Drug. The FDA reported the reason for recall as presence of foreign tablets/capsules. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-1005-2020

Reason for Recall
Presence of Foreign Tablets/Capsules: Complaint involving one Women's Prenatal dietary supplement tablet commingled in a bottle of Extra Strength Acetaminophen 500 mg contents 1000 count bottle
Initiated
03-06-2020
Reported
03-18-2020
Quantity
11,973 tablets

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
H J Harkins Company Inc dba Pharma Pac
Nationwide within the United States
Acetaminophen 500 mg tablet packaged in a) 30-count bottles ( NDC 52959-0002-30), b) 42-count bottles (NDC 52959-0002-42), c) 45-count bottles (NDC 52959-0002-45) and e) 50-count bottles (NDC 52959-0002-50) Repack: H.J. Harkins Co., Inc. Grover Beach, CA 93433

Batch or Lot Expiration Information

Lot# : AE00M, exp. date 08/2021